(Q95407461)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22951890%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

title

Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22951890%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22951890%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

Axel C Carlsson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22951890%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

Johan Sundström

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22951890%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

6

Lars Lind

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22951890%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

author name string

Erik Ingelsson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22951890%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

Anders Larsson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22951890%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

Tobias E Larsson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22951890%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

publication date

5 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22951890%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22951890%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22951890%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22951890%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

page(s)

160-166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22951890%20AND%20SRC:MED&resulttype=core&format=json

Mineral metabolism and vitamin D in chronic kidney disease--more questions than answers

24 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Plasma parathyroid hormone and the risk of cardiovascular mortality in the community

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the Community

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

FGF23 induces left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Relationship between circulating FGF23 and total body atherosclerosis in the community

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Indirect regulation of PTH by estrogens may require FGF23.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Associations of estradiol and testosterone with serum phosphorus in older men: the Osteoporotic Fractures in Men study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Adrenal responses to subtotal parathyroidectomy for primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Low dietary intake of beta-carotene, alpha-tocopherol and ascorbic acid is associated with increased inflammatory and oxidative stress status in a Swedish cohort

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

The progression from hypertension to congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.327

7 January 2021

Identifiers

DOI

10.1038/KI.2012.327

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22951890%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

1 reference